The effect of adolescent and advanced-age pregnancies on maternal and early neonatal clinical data

Pinar Yavuz1, Mustafa Taze2, Ozgul Salihoglu3

  • 1Department of Pediatrics, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey.

Insights

Newborns from adolescent and advanced maternal age pregnancies face higher risks in the early postnatal period. Careful clinical management and follow-up are crucial for these infants.

Area of Science:

  • Perinatology
  • Neonatology
  • Maternal-fetal Medicine

Background:

  • Pregnancy outcomes can be influenced by maternal age, with adolescent and advanced maternal age (AMA) posing distinct risks.
  • Early postnatal clinical data are critical for identifying and managing potential complications in newborns.
  • Understanding these risks is essential for optimizing pediatric care and maternal health strategies.

Purpose of the Study:

  • To compare early postnatal clinical findings in infants born to adolescent mothers and advanced maternal age (AMA) mothers with those born to mothers aged 20-34 years.
  • To identify specific risks and clinical outcomes associated with adolescent and AMA pregnancies.
  • To inform clinical management and follow-up protocols for newborns from these maternal age groups.

Main Methods:

  • Retrospective study of 1676 newborns and 1638 mothers delivering between January 2017 and January 2018.
  • Data collected included maternal demographics, clinical history, and neonatal anthropometrics and early delivery room data.
  • Comparison of outcomes between adolescent mothers, AMA mothers, and a control group (mothers aged 20-34 years).

Main Results:

  • Newborns of adolescent and AMA mothers had significantly higher intensive care admission/referral rates compared to the control group.
  • AMA mothers showed higher rates of Cesarean sections, abortion, smoking, and their newborns had higher rates of LGA (large for gestational age) and macrosomia.
  • Newborns of AMA mothers had lower 1-minute APGAR scores and higher pCO2 levels; newborns of adolescent mothers had higher lactate values, though healthy adolescent pregnancies showed lower resuscitation needs.

Conclusions:

  • Infants born to adolescent and AMA mothers are at increased risk for adverse early postnatal clinical findings.
  • The early postnatal period is critical for managing newborns from these maternal age groups.
  • Tailored pediatric management strategies are essential for improving outcomes in this vulnerable population.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.2K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
59
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.6K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
45
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
47
Oogenesis02:07

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
67.1K